Cidofovir

Basic Information

Item Value
DrugBank ID DB00369
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 72

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 sclerosing cholangitis KG + DL
2 rheumatoid arthritis KG + DL
3 colobomatous microphthalmia-rhizomelic dysplasia syndrome KG + DL
4 brachydactyly-syndactyly syndrome KG + DL
5 osteoarthritis susceptibility KG + DL
6 autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome KG + DL
7 gout KG + DL
8 brain small vessel disease 1 with or without ocular anomalies KG + DL
9 diabetic nephropathy KG + DL
10 osteoarthritis KG + DL
11 infectious otitis media KG + DL
12 WHIM syndrome KG + DL
13 brachyolmia KG + DL
14 acromesomelic dysplasia, Hunter-Thompson type KG + DL
15 middle ear cholesterol granuloma KG + DL
16 IgG4-related pachymeningitis KG + DL
17 brachyolmia-amelogenesis imperfecta syndrome KG + DL
18 otosalpingitis KG + DL
19 IgG4-related sclerosing cholangitis KG + DL
20 middle ear disease KG + DL
21 myosclerosis KG + DL
22 chronic otitis media KG + DL
23 non-suppurative otitis media KG + DL
24 allergic otitis media KG + DL
25 suppurative otitis media KG + DL
26 IgG4-related retroperitoneal fibrosis KG + DL
27 IgG4-related mediastinitis KG + DL
28 IgG4-related aortitis KG + DL
29 eosinophilic angiocentric fibrosis KG + DL
30 IgG4-related mesenteritis KG + DL
31 arthropathy KG + DL
32 Lyme disease KG + DL
33 IgG4-related hepatopathy KG + DL
34 bronchitis KG + DL
35 cholangitis KG + DL
36 pseudoachondroplasia KG + DL
37 meningococcal infection KG + DL
38 urinary tract infection (disease) KG + DL
39 suppurative cholangitis KG + DL
40 congestive heart failure KG + DL
41 gonococcal urethritis KG + DL
42 Ureaplasma urethritis KG + DL
43 type I complement component 8 deficiency KG + DL
44 methemoglobinemia, alpha type KG + DL
45 pneumonia KG + DL
46 epiglottitis KG + DL
47 pleural adenomatoid tumor KG + DL
48 malignant peritoneal mesothelioma KG + DL
49 acute pulmonary heart disease KG + DL
50 pleural biphasic mesothelioma KG + DL

(Showing top 50 of 72 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). 本報告僅供研究參考,不構成醫療建議。

This site uses Just the Docs, a documentation theme for Jekyll.